These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15892904)

  • 1. An evaluation of persisting cognitive effects after withdrawal from long-term benzodiazepine use.
    Barker MJ; Greenwood KM; Jackson M; Crowe SF
    J Int Neuropsychol Soc; 2005 May; 11(3):281-9. PubMed ID: 15892904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis.
    Barker MJ; Greenwood KM; Jackson M; Crowe SF
    Arch Clin Neuropsychol; 2004 Apr; 19(3):437-54. PubMed ID: 15033227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of benzodiazepines on cognition.
    Stewart SA
    J Clin Psychiatry; 2005; 66 Suppl 2():9-13. PubMed ID: 15762814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory dysfunction in panic disorder: an investigation of the role of chronic benzodiazepine use.
    Deckersbach T; Moshier SJ; Tuschen-Caffier B; Otto MW
    Depress Anxiety; 2011 Nov; 28(11):999-1007. PubMed ID: 22065537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological profile of cognitively impaired patients with schizophrenia.
    Bozikas VP; Kosmidis MH; Kiosseoglou G; Karavatos A
    Compr Psychiatry; 2006; 47(2):136-43. PubMed ID: 16490572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
    J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cognitive dysfunctions in patients with alcohol dependence].
    Nowakowska K; Jabłkowska K; Borkowska A
    Psychiatr Pol; 2007; 41(5):693-702. PubMed ID: 18421924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging.
    Michaud K; Forget H; Cohen H
    Brain Cogn; 2009 Oct; 71(1):1-8. PubMed ID: 19428166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired cognitive performance in patients with chronic burnout syndrome.
    Sandström A; Rhodin IN; Lundberg M; Olsson T; Nyberg L
    Biol Psychol; 2005 Jul; 69(3):271-9. PubMed ID: 15925030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual dysfunction in Parkinson disease without dementia.
    Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
    Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The absence of benzodiazepine craving in a general practice benzodiazepine discontinuation trial.
    Mol AJ; Oude Voshaar RC; Gorgels WJ; Breteler MH; van Balkom AJ; van de Lisdonk EH; Kan CC; Mulder J; Zitman FG
    Addict Behav; 2006 Feb; 31(2):211-22. PubMed ID: 15951127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive dysfunction in antidepressant-free, non-elderly patients with unipolar depression: alerting and covert orienting of visuospatial attention.
    Pardo JV; Pardo PJ; Humes SW; I Posner M
    J Affect Disord; 2006 May; 92(1):71-8. PubMed ID: 16458363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological functioning, illness perception, mood and quality of life in chronic fatigue syndrome, autoimmune thyroid disease and healthy participants.
    Dickson A; Toft A; O'Carroll RE
    Psychol Med; 2009 Sep; 39(9):1567-76. PubMed ID: 19144216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predicting the success of a benzodiazepine discontinuation programme: myths or clinical wisdom?].
    Knoop H; Kan CC; Mickers FC; Barnhoorn D
    Tijdschr Psychiatr; 2006; 48(9):695-703. PubMed ID: 17007475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.
    Gehring K; Sitskoorn MM; Gundy CM; Sikkes SA; Klein M; Postma TJ; van den Bent MJ; Beute GN; Enting RH; Kappelle AC; Boogerd W; Veninga T; Twijnstra A; Boerman DH; Taphoorn MJ; Aaronson NK
    J Clin Oncol; 2009 Aug; 27(22):3712-22. PubMed ID: 19470928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive effects of long-term benzodiazepine use in older adults.
    Pat McAndrews M; Weiss RT; Sandor P; Taylor A; Carlen PL; Shapiro CM
    Hum Psychopharmacol; 2003 Jan; 18(1):51-7. PubMed ID: 12532315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure is associated with cognitive impairment in young hypertensives.
    Gupta R; Solanki RK; Pathak V
    World J Biol Psychiatry; 2008; 9(1):43-50. PubMed ID: 17853255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.